Home
PRQR
PRQR News

Latest ProQR Therapeutics N.V. (PRQR) News on August 30, 2025

MT Newswires

2 months ago

ProQR Seeks EU Approval for Liver Cell Protein Trial

ProQR Announces CTA Submission for Phase 1 Study of AX-0810 Targeting NTCP

GlobeNewswire

2 months ago

ProQR Announces CTA Submission for Phase 1 Study of AX-0810 Targeting NTCP

MT Newswires

4 months ago

Oppenheimer Adjusts ProQR Therapeutics N.V Price Target to $9 From $15, Maintains Outperform Rating

ProQR Announces Upcoming Scientific Presentations at ASGCT and TIDES Conferences

GlobeNewswire

4 months ago

ProQR Announces Upcoming Scientific Presentations at ASGCT and TIDES Conferences

New Forecasts: Here's What Analysts Think The Future Holds For ProQR Therapeutics N.V. (NASDAQ:PRQR)

Simply Wall St.

4 months ago

New Forecasts: Here's What Analysts Think The Future Holds For ProQR Therapeutics N.V. (NASDAQ:PRQR)

ProQR Announces First Quarter 2025 Operating and Financial Results

GlobeNewswire

4 months ago

ProQR Announces First Quarter 2025 Operating and Financial Results

ProQR Announces Webcast of Presentation at the 2025 Citizens Life Sciences Conference

GlobeNewswire

4 months ago

ProQR Announces Webcast of Presentation at the 2025 Citizens Life Sciences Conference

ProQR Announces Annual General Meeting of Shareholders to be Held June 3, 2025

GlobeNewswire

4 months ago

ProQR Announces Annual General Meeting of Shareholders to be Held June 3, 2025

ProQR Therapeutics assumed with an Overweight at Cantor Fitzgerald

TipRanks

4 months ago

ProQR Therapeutics assumed with an Overweight at Cantor Fitzgerald

ProQR Therapeutics initiated with an Outperform at Evercore ISI

TipRanks

4 months ago

ProQR Therapeutics initiated with an Outperform at Evercore ISI

ProQR Strengthens Leadership with Appointments of CFO and CMO to Support Next Phase of Growth

GlobeNewswire

5 months ago

ProQR Strengthens Leadership with Appointments of CFO and CMO to Support Next Phase of Growth

ProQR Therapeutics Full Year 2024 Earnings: Misses Expectations

Simply Wall St.

6 months ago

ProQR Therapeutics Full Year 2024 Earnings: Misses Expectations

ProQR Announces Year End 2024 Operating and Financial Results

GlobeNewswire

6 months ago

ProQR Announces Year End 2024 Operating and Financial Results

MT Newswires

6 months ago

Citigroup Upgrades ProQR Therapeutics to Buy From Neutral, Price Target is $4

ProQR Therapeutics N.V.'s (NASDAQ:PRQR) largest shareholders are individual investors with 60% ownership, institutions own 17%

Simply Wall St.

7 months ago

ProQR Therapeutics N.V.'s (NASDAQ:PRQR) largest shareholders are individual investors with 60% ownership, institutions own 17%

Is There An Opportunity With ProQR Therapeutics N.V.'s (NASDAQ:PRQR) 37% Undervaluation?

Simply Wall St.

8 months ago

Is There An Opportunity With ProQR Therapeutics N.V.'s (NASDAQ:PRQR) 37% Undervaluation?

ProQR Therapeutics announces $8.1M in new funding from RSRT

TipRanks

9 months ago

ProQR Therapeutics announces $8.1M in new funding from RSRT

ProQR Therapeutics Announces $8.1 Million in New Funding from Rett Syndrome Research Trust to Expand RNA Editing Collaboration

GlobeNewswire

9 months ago

ProQR Therapeutics Announces $8.1 Million in New Funding from Rett Syndrome Research Trust to Expand RNA Editing Collaboration

ProQR Appoints Peter A. Beal, PhD, as Chief ADAR Scientist

GlobeNewswire

9 months ago

ProQR Appoints Peter A. Beal, PhD, as Chief ADAR Scientist

ProQR Therapeutics price target raised to $8 from $5 at JMP Securities

TipRanks

9 months ago

ProQR Therapeutics price target raised to $8 from $5 at JMP Securities

ProQR Therapeutics to Host Virtual Analyst and Investor Event on December 11, 2024

GlobeNewswire

9 months ago

ProQR Therapeutics to Host Virtual Analyst and Investor Event on December 11, 2024

ProQR Therapeutics Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St.

10 months ago

ProQR Therapeutics Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

ProQR Therapeutics sees cash runway into mid-2027

TipRanks

10 months ago

ProQR Therapeutics sees cash runway into mid-2027

ProQR Announces Third Quarter 2024 Operating and Financial Results

GlobeNewswire

10 months ago

ProQR Announces Third Quarter 2024 Operating and Financial Results

ProQR Announces Closing of Underwritten Public Offering and Concurrent Private Placement

GlobeNewswire

10 months ago

ProQR Announces Closing of Underwritten Public Offering and Concurrent Private Placement

ProQR Prices $75 Million Underwritten Public Offering and Concurrent Private Placement

GlobeNewswire

10 months ago

ProQR Prices $75 Million Underwritten Public Offering and Concurrent Private Placement

ProQR Announces Proposed Underwritten Public Offering of Ordinary Shares

GlobeNewswire

10 months ago

ProQR Announces Proposed Underwritten Public Offering of Ordinary Shares

Gevo And 2 Other US Penny Stocks To Watch Closely

Simply Wall St.

10 months ago

Gevo And 2 Other US Penny Stocks To Watch Closely

ProQR Therapeutics (NASDAQ:PRQR) shareholder returns have been solid, earning 231% in 1 year

Simply Wall St.

10 months ago

ProQR Therapeutics (NASDAQ:PRQR) shareholder returns have been solid, earning 231% in 1 year

ProQR Highlights Upcoming Presentation at 20th Annual Meeting of the Oligonucleotide Therapeutics Society

GlobeNewswire

a year ago

ProQR Highlights Upcoming Presentation at 20th Annual Meeting of the Oligonucleotide Therapeutics Society

ProQR Announces Webcast Presentation at the 2024 Cantor Global Healthcare Conference

GlobeNewswire

a year ago

ProQR Announces Webcast Presentation at the 2024 Cantor Global Healthcare Conference

ProQR Therapeutics Second Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St.

a year ago

ProQR Therapeutics Second Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

ProQR Announces Second Quarter 2024 Operating and Financial Results

GlobeNewswire

a year ago

ProQR Announces Second Quarter 2024 Operating and Financial Results

Institutions own 25% of ProQR Therapeutics N.V. (NASDAQ:PRQR) shares but retail investors control 46% of the company

Simply Wall St.

a year ago

Institutions own 25% of ProQR Therapeutics N.V. (NASDAQ:PRQR) shares but retail investors control 46% of the company

ProQR Announces Presentation on its Axiomer™ RNA Editing Technology at RNA Editing Summit

GlobeNewswire

a year ago

ProQR Announces Presentation on its Axiomer™ RNA Editing Technology at RNA Editing Summit

5 Reasons a Biden Second Term Could Be a Financial Disaster for Boomers

GOBankingRates

a year ago

5 Reasons a Biden Second Term Could Be a Financial Disaster for Boomers

Bumrah delivers as India beat Pakistan in low-scoring thriller

AFP

a year ago

Bumrah delivers as India beat Pakistan in low-scoring thriller

Italy beat Bosnia in final Euros warm-up

AFP

a year ago

Italy beat Bosnia in final Euros warm-up

Trump loyalists proud to support 'felon' at Las Vegas rally

AFP

a year ago

Trump loyalists proud to support 'felon' at Las Vegas rally

US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia

Business Insider

a year ago

US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia

The Best Woody Perfume For Women

Insider Monkey

a year ago

The Best Woody Perfume For Women

Microsoft unveils all-digital Xbox consoles, 'Doom' title at Games Showcase

Reuters

a year ago

Microsoft unveils all-digital Xbox consoles, 'Doom' title at Games Showcase

Insider Monkey

a year ago

Best Date Night Fragrance in 2024

Shareholders in ProQR Therapeutics (NASDAQ:PRQR) are in the red if they invested five years ago

Simply Wall St.

a year ago

Shareholders in ProQR Therapeutics (NASDAQ:PRQR) are in the red if they invested five years ago

ProQR Announces First Quarter 2024 Operating and Financial Results

GlobeNewswire

a year ago

ProQR Announces First Quarter 2024 Operating and Financial Results

ProQR Announces Preclinical Proof of Concept Data for AX-0810 Axiomer™ RNA Editing Program Targeting NTCP for Cholestatic Diseases

GlobeNewswire

a year ago

ProQR Announces Preclinical Proof of Concept Data for AX-0810 Axiomer™ RNA Editing Program Targeting NTCP for Cholestatic Diseases

ProQR Nominates Martin Maier, PhD to Board and Announces Annual Meeting of Shareholders to be Held May 22, 2024

GlobeNewswire

a year ago

ProQR Nominates Martin Maier, PhD to Board and Announces Annual Meeting of Shareholders to be Held May 22, 2024

ProQR Highlights Upcoming Presentations on Axiomer™ RNA Editing at ASGCT 27th Annual Meeting

GlobeNewswire

a year ago

ProQR Highlights Upcoming Presentations on Axiomer™ RNA Editing at ASGCT 27th Annual Meeting

ProQR Achieves Successful Defense of New Challenge to its Axiomer™ IP Portfolio

GlobeNewswire

a year ago

ProQR Achieves Successful Defense of New Challenge to its Axiomer™ IP Portfolio

ProQR Therapeutics Full Year 2023 Earnings: Misses Expectations

Simply Wall St.

a year ago

ProQR Therapeutics Full Year 2023 Earnings: Misses Expectations

ProQR Announces Year End 2023 Operating and Financial Results

GlobeNewswire

a year ago

ProQR Announces Year End 2023 Operating and Financial Results

ProQR Announces Japanese Axiomer™ Patent Upheld Following Opposition Against Its Leading IP Estate for ADAR-mediated RNA Editing

GlobeNewswire

2 years ago

ProQR Announces Japanese Axiomer™ Patent Upheld Following Opposition Against Its Leading IP Estate for ADAR-mediated RNA Editing

LSI Industries Inc. (NASDAQ:LYTS) Q2 2024 Earnings Call Transcript

Insider Monkey

2 years ago

LSI Industries Inc. (NASDAQ:LYTS) Q2 2024 Earnings Call Transcript

Keen Vision Acquisition Corporation (NASDAQ:KVAC) most popular amongst retail investors who own 45% of the shares, institutions hold 32%

Simply Wall St.

2 years ago

Keen Vision Acquisition Corporation (NASDAQ:KVAC) most popular amongst retail investors who own 45% of the shares, institutions hold 32%

ProQR Highlights New Platform Data from Presentation on Axiomer™ RNA Editing Technology at Deaminet 2024

GlobeNewswire

2 years ago

ProQR Highlights New Platform Data from Presentation on Axiomer™ RNA Editing Technology at Deaminet 2024

While institutions invested in ProQR Therapeutics N.V. (NASDAQ:PRQR) benefited from last week's 12% gain, individual investors stood to gain the most

Simply Wall St.

2 years ago

While institutions invested in ProQR Therapeutics N.V. (NASDAQ:PRQR) benefited from last week's 12% gain, individual investors stood to gain the most

ProQR and Rett Syndrome Research Trust Join Forces with Axiomer™ RNA Editing Collaboration

GlobeNewswire

2 years ago

ProQR and Rett Syndrome Research Trust Join Forces with Axiomer™ RNA Editing Collaboration

Is ProQR (PRQR) Stock a Solid Choice Right Now?

Zacks

2 years ago

Is ProQR (PRQR) Stock a Solid Choice Right Now?

Is PennantPark Investment (PNNT) Stock Undervalued Right Now?

Zacks

2 years ago

Is PennantPark Investment (PNNT) Stock Undervalued Right Now?

Why Intrepid Potash Stock Is Popping This Week

Motley Fool

2 years ago

Why Intrepid Potash Stock Is Popping This Week

ProQR Therapeutics Announces Transaction Completed for Théa to Acquire Sepofarsen and Ultevursen Ophthalmic Assets

GlobeNewswire

2 years ago

ProQR Therapeutics Announces Transaction Completed for Théa to Acquire Sepofarsen and Ultevursen Ophthalmic Assets

W&T (WTI) Down 13.1% Since Last Earnings Report: Can It Rebound?

Zacks

2 years ago

W&T (WTI) Down 13.1% Since Last Earnings Report: Can It Rebound?

Wall Street Analysts Think Legacy Housing (LEGH) Could Surge 27.38%: Read This Before Placing a Bet

Zacks

2 years ago

Wall Street Analysts Think Legacy Housing (LEGH) Could Surge 27.38%: Read This Before Placing a Bet

5 Small Hidden Gems for the Rest of 2023

Zacks

2 years ago

5 Small Hidden Gems for the Rest of 2023

TRC: Low LA Region Industrial Vacancies, Rising Lease Rates Expected Catalysts for Continued Strong Demand at TRCC

Zacks Small Cap Research

2 years ago

TRC: Low LA Region Industrial Vacancies, Rising Lease Rates Expected Catalysts for Continued Strong Demand at TRCC

Forge Global Holdings, Inc. (NYSE:FRGE) Q3 2023 Earnings Call Transcript

Insider Monkey

2 years ago

Forge Global Holdings, Inc. (NYSE:FRGE) Q3 2023 Earnings Call Transcript

Thomson Reuters StreetEvents

2 years ago

Q3 2023 WEYCO Group Inc Earnings Call

Associated Press Finance

2 years ago

Weyco: Q3 Earnings Snapshot

GlobeNewswire

2 years ago

Weyco Reports Third Quarter Sales and Earnings

ProQR Announces Third Quarter 2023 Operating and Financial Results

GlobeNewswire

2 years ago

ProQR Announces Third Quarter 2023 Operating and Financial Results

Pioneer Closed End Funds Required Notice to Shareholders Sources of Distribution Under Section 19(a)

Business Wire

2 years ago

Pioneer Closed End Funds Required Notice to Shareholders Sources of Distribution Under Section 19(a)

Share on Social Networks: